OncoMed closes $154m financing round

The clinical-stage pharmaceuticals company, now conducting human clinical trials, has added new investor Nomura Phase4 Ventures to its roster of venture backers in the $93m final tranche.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this